Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy.
Eur J Dermatol. 2021 Jun 1;31(3):307-317. doi: 10.1684/ejd.2021.4056.
Eur J Dermatol. 2021.
PMID: 34309516